Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Type A Versus Type B
Rancho Mirage, Calif. -- A recent study rating the effects of botulinum toxin B in the treatment of hyperkinetic facial wrinkles showed that Myobloc is an effective treatment for interglabellar wrinkles. And while Myobloc showed some advantages over the more commonly used Botox (botulinum toxin A), the longevity of the treatment is about one or two weeks less, even at higher dosages.
Related Videos
Related Content
